Patients with irritable bowel syndrome in primary care appear not to be heavy healthcare utilizers
- 27 February 2006
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 23 (6) , 807-814
- https://doi.org/10.1111/j.1365-2036.2006.02815.x
Abstract
Summary: Background: Irritable bowel syndrome is a frequently diagnosed gastrointestinal condition in general practice. Managing this chronic condition requires a co‐ordinated effort between patient and doctor.Aim: To explore the patterns of treatment and healthcare utilization of irritable bowel syndrome cases in a Swedish primary care setting.Methods: All cases with a registered diagnosis of irritable bowel syndrome were identified retrospectively for a 5‐year period through computerized medical records at three primary healthcare centres in Sweden. Documentation of diagnosis, healthcare visits, treatments, investigations, medications, referrals, laboratory tests, mental and demographic data were retrieved from the records.Results: Of all 723 irritable bowel syndrome patients identified, only 37% had a follow‐up appointment to their General Practitioner during the study period. For 80%, the General Practitioner initiated some treatment during the initial consultation and 75% were prescribed medication. Fibre and bulking laxatives and acid‐suppressive drugs were the most common medication. Almost a quarter was referred for complementary investigations at hospital, only 8.9% of the irritable bowel syndrome patients were referred to a specialist investigation. Laboratory investigations varied and were ordered more frequently (P = 0.05) for men.Conclusions: Irritable bowel syndrome patients appear not to be heavy utilizers of primary care and, of those who attend, the majority are managed by their General Practitioner.Keywords
This publication has 21 references indexed in Scilit:
- Doctor–patient interaction for irritable bowel syndrome in primary careEuropean Journal of Gastroenterology & Hepatology, 2004
- Diagnosis and therapy of irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2004
- Update in the pharmaceutical therapy of the irritable bowel syndromeInternational Journal Of Clinical Practice, 2004
- Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders 1 1This study was registered with ClinicalTrials.gov (trial registry no. NCT00006157).Gastroenterology, 2003
- Alimentary Pharmacology & TherapeuticsAlimentary Pharmacology & Therapeutics, 1999
- Irritable bowel syndrome: A multibillion-dollar problemGastroenterology, 1995
- Bran and irritable bowel syndrome: time for reappraisalThe Lancet, 1994
- Doubts about branThe Lancet, 1994
- Irritable bowel syndrome in the general population.BMJ, 1992
- FOOD INTOLERANCE: A MAJOR FACTOR IN THE PATHOGENESIS OF IRRITABLE BOWEL SYNDROMEThe Lancet, 1982